| |
|
|
|
Aeglea Biothera  
|
|
7.68 -0.35 (-0.04%) |
10-23 16:00 |
|
Open: |
8.09 |
Pre close: |
8.03 |
Target:
|
10.20
|
|
High: |
8.09 |
Low: |
7.63 |
Resistance:
|
8.73
10.20
|
|
Volume: |
1,605,769 |
Market Cap: |
343M |
Support:
|
7.42
6.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.93
 |
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
7.72  |
Signal(12,26,9): |
0.19 |
|
MA(100): |
7.82 |
Stochastic Oscillator |
%K(14,3):
|
48.33 |
|
MA(250): |
7.44 |
%D(3): |
54.19 |
|
Average Volume(K) |
3-Month: |
33317
|
52-Week |
High:
|
11.38 |
|
10-Days: |
47017 |
Low: |
3.50 |
|
RSI |
RSI(14):
|
49.90 |
Change(%): |
-0.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.190 |
Return on Equity (ttm) |
-66.1 |
Shares Out. (M) |
44.60 |
|
EPS Est. Current Year |
-2.070 |
Return on Assets (ttm) |
-36.4 |
Shares Float (M) |
24.24 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.08 |
|
EPS Est. Next Quarter |
-0.580 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
57.82 |
|
Forward EPS |
-2.450 |
Gross Profit (p.s.) |
-1.448 |
Shares Short (K) |
2670 |
|
Book Value (p.s.) |
3.410 |
EBITDA (p.s.) |
-1.885 |
P/E |
-3.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-74.61 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-47.62 |
P/CF |
-4.59 |
|
|
|
|
|
|
